Low-Dose d-Amphetamine Induced Regression of Liver Fat Deposits in Dercum Disease

There is a dire need for novel treatment options for nonalcoholic fatty liver disease to prevent progression to cirrhosis. Reduction of liver fat by d-amphetamine suggests a potential therapeutic role in nonalcoholic fatty liver disease.